Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for Antares Pharma Inc (ATRS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2017 Q4 | 50,000 | <0.01 | $2.00 | $100,000 | SEC | ||
| 2017 Q3 | 50,000 | <0.01 | Add 150.00% | <0.01 | $3.24 | $162,000 | SEC |
| 2017 Q2 | 20,000 | <0.01 | $3.20 | $64,000 | SEC | ||
| 2017 Q1 | 20,000 | <0.01 | $2.85 | $57,000 | SEC | ||
| 2016 Q4 | 20,000 | <0.01 | $2.35 | $47,000 | SEC | ||
| 2016 Q3 | 20,000 | <0.01 | $1.70 | $34,000 | SEC | ||
| 2016 Q2 | 20,000 | <0.01 | $1.05 | $21,000 | SEC | ||
| 2016 Q1 | 20,000 | 0.00 | $0.85 | $17,000 | SEC | ||
| 2015 Q4 | 20,000 | <0.01 | $1.20 | $24,000 | SEC | ||
| 2015 Q3 | 20,000 | <0.01 | $1.70 | $34,000 | SEC | ||
| 2015 Q2 | 20,000 | <0.01 | $2.10 | $42,000 | SEC | ||
| 2015 Q1 | 20,000 | <0.01 | $2.70 | $54,000 | SEC | ||
| 2014 Q4 | 20,000 | <0.01 | $2.55 | $51,000 | SEC | ||
| 2014 Q3 | 20,000 | <0.01 | $1.85 | $37,000 | SEC | ||
| 2014 Q2 | 20,000 | <0.01 | $2.65 | $53,000 | SEC | ||
| 2014 Q1 | 20,000 | <0.01 | $3.50 | $70,000 | SEC | ||
| 2013 Q4 | 20,000 | <0.01 | $4.50 | $90,000 | SEC | ||
| 2013 Q3 | 20,000 | <0.01 | $4.05 | $81,000 | SEC | ||
| 2013 Q2 | 20,000 | <0.01 | Buy | <0.01 | $4.15 | $83,000 | SEC |